Inventor
YASUDA NOBUYOSHI
US66 patents
⚠️ This page may combine multiple inventors who share the name “YASUDA NOBUYOSHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
17 patentsUS5633405AMay 27, 1997
Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one
MERCK & CO INC21 citations92
US6407241B1Jun 18, 2002
Process and intermediates for the preparation of imidazolidinone αv integrin antagonists
MERCK & CO INC19 citations82
US7301026B2Nov 27, 2007
Process for making fluorinated 4-azasteroid derivatives
MERCK & CO INC10 citations80
US5338875AAug 16, 1994
Boron containing intermediates useful in the preparation of carbapenems
MERCK & CO INC19 citations79
US5698741ADec 16, 1997
Asymmetric synthesis of (-)6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
MERCK & CO INC5 citations74
US7074930B2Jul 11, 2006
Amine salts of an integrin receptor antagonist
MERCK & CO INC10 citations73
US5434152AJul 18, 1995
Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone
MERCK & CO INC13 citations73
US6706885B2Mar 16, 2004
Process for preparing integrin antagonist intermediates
MERCK & CO INC2 citations62
US6262268B1Jul 17, 2001
Process and intermediates to a tetrahydro-[1,8]-naphthyridine
MERCK & CO INC4 citations62
US5783709AJul 21, 1998
Stereoselective process for making substituted amino acid derivatives
MERCK & CO INC2 citations62
US5457201AOct 10, 1995
Chiral resolution process
MERCK & CO INC4 citations62
US6646130B2Nov 11, 2003
Process to chiral integrin antagonist beta-amino acid intermediate
MERCK & CO INC2 citations61
US6423845B1Jul 23, 2002
Process and intermediates to a tetrahydro-[1,8]- Naphthyridine
MERCK & CO INC4 citations61
US6048978AApr 11, 2000
Process for the synthesis of carbapenem intermediates, and compounds produced
MERCK & CO INC2 citations61
US6346617B1Feb 12, 2002
Crystalline 2-hydroxymethyl carbapenem intermediate compounds and process for synthesis thereof
MERCK & CO INC3 citations60
US5426230AJun 20, 1995
Process for the preparation of 4-chloro-2-cyclopropylcarbonylaniline
MERCK & CO INC4 citations60
US6080854AJun 27, 2000
Process for synthesizing carbapenem intermediates
MERCK & CO INC4 citations58
MERCK SHARP & DOHME
15 patentsUS9822121B2Nov 21, 2017
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME13 citations92
US10106541B2Oct 23, 2018
Intermediates for preparing CGRP receptor antagonists
MERCK SHARP & DOHME16 citations91
US9850246B2Dec 26, 2017
Process for making CGRP receptor antagonists
MERCK SHARP & DOHME17 citations91
US9174989B2Nov 3, 2015
Process for making CGRP receptor antagonists
MERCK SHARP & DOHME19 citations91
US11708371B2Jul 25, 2023
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME3 citations83
US11124478B2Sep 21, 2021
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME5 citations83
US10899771B2Jan 26, 2021
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME7 citations83
US10577316B2Mar 3, 2020
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME9 citations83
US10435410B2Oct 8, 2019
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME9 citations83
US10087189B2Oct 2, 2018
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME10 citations83
US9809536B2Nov 7, 2017
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME12 citations83
US9376431B2Jun 28, 2016
Bis-quaternary cinchona alkaloid salts as asymmetric phase transfer catalysts
MERCK SHARP & DOHME16 citations82
US9487523B2Nov 8, 2016
Process for making CGRP receptor antagonists
MERCK SHARP & DOHME17 citations81
US11767292B2Sep 26, 2023
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME3 citations72
US9604985B2Mar 28, 2017
Process for the preparation of chiral tert-butyl 4-((1R,2S,5R)-6(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carb derivatives and (2S,5R)-7-oxo-N-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
MERCK SHARP & DOHME3 citations72
FUJISAWA PHARMACEUTICAL CO
11 patentsUS5104866AApr 14, 1992
Water-soluble antibiotic composition and water-soluble salts of cephem compounds
FUJISAWA PHARMACEUTICAL CO20 citations82
US4871730AOct 3, 1989
Cephem compounds
FUJISAWA PHARMACEUTICAL CO18 citations82
US4493831AJan 15, 1985
Aminoglycoside derivatives
FUJISAWA PHARMACEUTICAL CO23 citations82
US4420477ADec 13, 1983
Cephem compounds
FUJISAWA PHARMACEUTICAL CO17 citations82
US4861769AAug 29, 1989
Cephem compounds
FUJISAWA PHARMACEUTICAL CO17 citations78
US4656160AApr 7, 1987
Aminoglycoside derivatives
FUJISAWA PHARMACEUTICAL CO13 citations74
US4622318ANov 11, 1986
3-(substituted-ethenyl or ethynyl-thiomethyl) cephems
FUJISAWA PHARMACEUTICAL CO18 citations74
US4582908AApr 15, 1986
1-substituted-5-thiol-tetrazole intermediates
FUJISAWA PHARMACEUTICAL CO4 citations74
US4554269ANov 19, 1985
Kasugamycin derivatives, pharmaceutical compositions and method of use
FUJISAWA PHARMACEUTICAL CO9 citations74
US4985555AJan 15, 1991
Cephem compounds
FUJISAWA PHARMACEUTICAL CO2 citations63
US4493834AJan 15, 1985
Cephem compounds
FUJISAWA PHARMACEUTICAL CO1 citations63
KURASHIKI BOSEKI KK
4 patentsUS6101405AAug 8, 2000
Method and device for positioning a living body
KURASHIKI BOSEKI KK35 citations92
US6078828AJun 20, 2000
Pressure regulating device and method of regulating pressure applied to living body during biodata measurement
KURASHIKI BOSEKI KK41 citations92
US6449500B1Sep 10, 2002
Probe for optical measurement
KURASHIKI BOSEKI KK44 citations89
US6618615B1Sep 9, 2003
Apparatus for and method of measuring body fat
KURASHIKI BOSEKI KK10 citations72
(unassigned)
2 patentsYASUDA NOBUYOSHI
1 patentShowing the top 50 of 66 patents by PatentIndex Score.